Clostridium difficile infection: a common clinical problem for the general internist

Area of Science:

• Infectious Diseases
• Gastroenterology
• Internal Medicine

Background:

• Widespread antimicrobial agent use frequently exposes patients to Clostridioides difficile (C. difficile) infection risk.
• C. difficile infection (CDI) presents a spectrum of illness, from mild diarrhea to severe colitis, necessitating timely diagnosis and management.
• General internists frequently encounter patients at risk for CDI, highlighting the need for awareness and diagnostic acumen.

Purpose of the Study:

• To outline diagnostic considerations for C. difficile infection in patients with recent antibiotic exposure.
• To review current therapeutic strategies for C. difficile infection, including standard and emerging treatments.
• To emphasize preventive measures against C. difficile transmission and infection.

Main Methods:

• Diagnosis relies primarily on detecting C. difficile toxin in stool samples.
• Adjunctive diagnostic methods include stool culture and fiberoptic endoscopy in specific clinical scenarios.
• Treatment strategies are guided by symptom severity, aiming to restore normal colonic flora.

Main Results:

• Oral vancomycin remains the gold standard for specific C. difficile infection treatment.
• Metronidazole is the first-line agent for milder infections.
• Discontinuing the offending antibiotic or using binding agents may suffice for minimally symptomatic cases.

Conclusions:

• Effective management of C. difficile infection involves accurate diagnosis and appropriate antimicrobial stewardship.
• Recurrent C. difficile infections may require prolonged vancomycin courses or combination therapy.
• Prevention strategies focus on judicious antibiotic use and infection control practices, such as glove use.